Evidence map›Paper›PMID 20349291›Full record

ReviewMedizinische Klinik (Munich, Germany : 1983)2010

[Cardiorenal syndrome].

Jan Galle

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Medizinische Klinik (Munich, Germany : 1983), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jan GalleKlinik für Nephrologie und Dialyseverfahren, Klinikum Lüdenscheid, Lüdenscheid. J.Galle@klinikum-luedenscheid.de
Klinikum Lüdenscheid · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With increasing age of a population, the rate and severity of comorbidities are also growing, resulting in a rising number of people with a condition described as "cardiorenal syndrome". Initially, cardiorenal syndrome defined the decline in cardiac and renal function due to diminished renal perfusion in the context of heart failure. However, in order to give consideration to the numerous comorbidities, nowadays the definition has been widened. Following a new classification, five types of cardiorenal syndrome are distinguished. Such a differentiation is helpful to find the appropriate therapeutic approach, according to the underlying disease. Therefore, the new classification and modern therapeutic concepts shall be presented here.

Indexed as

Combined Modality TherapyComorbidityCross-Sectional StudiesDiureticsHeart FailureHemodynamicsHumansIschemiaKidneyKidney Failure, ChronicKidney Function TestsRenal DialysisRenin-Angiotensin SystemRisk FactorsSympathetic Nervous SystemSyndromeDiuretics

Identifiers

PMID20349291
OpenAlexW1526990057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.